ANTIHEMOPHILIC FACTOR C, HUMAN is a medication specifically designed to replace factor VIII in individuals suffering from hemophilia A, a rare bleeding disorder. This protein-rich medication plays a vital role in the blood clotting process, thereby aiding in the prevention and control of bleeding episodes in affected patients. It is administered intravenously and is a crucial component of the management and prevention of bleeding incidents, particularly during surgery or injury.
9001-29-0
Post Buying Request-
-
Basic information
- Product Name: ANTIHEMOPHILIC FACTOR C, HUMAN
- Synonyms: COAGULATION FACTOR X, HUMAN PLASMA;HUMAN FACTOR X;FACTOR X (BOVINE);FACTOR X (HUMAN);STUART-POWER FACTOR, HUMAN;STUART PROWER FACTOR;STUART-PROWER FACTOR, HUMAN;Blood-coagulation factor X
- CAS NO:9001-29-0
- Molecular Formula:
- Molecular Weight: 0
- EINECS: 232-596-5
- Product Categories: N/A
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: -20°C
- Solubility: N/A
- CAS DataBase Reference: ANTIHEMOPHILIC FACTOR C, HUMAN(CAS DataBase Reference)
- NIST Chemistry Reference: ANTIHEMOPHILIC FACTOR C, HUMAN(9001-29-0)
- EPA Substance Registry System: ANTIHEMOPHILIC FACTOR C, HUMAN(9001-29-0)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 9001-29-0(Hazardous Substances Data)
9001-29-0 Suppliers
Recommended suppliers
9001-29-0 Usage
Uses
Used in Hemophilia A Treatment:ANTIHEMOPHILIC FACTOR C, HUMAN is used as a therapeutic agent for the treatment of hemophilia A, a condition characterized by a deficiency of factor VIII. It is administered as an intravenous injection to replenish the missing clotting factor, thereby helping to prevent and manage bleeding episodes in patients with this disorder.
Used in Surgical and Injury Management:
In the context of surgery or injury, ANTIHEMOPHILIC FACTOR C, HUMAN is used as a preventive and control measure to mitigate the risk of excessive bleeding. Its administration ensures that patients with hemophilia A maintain an adequate level of clotting factor during these critical events, reducing the likelihood of complications.
Used in Monitoring and Management of Side Effects:
Patients receiving ANTIHEMOPHILIC FACTOR C, HUMAN may experience side effects such as allergic reactions, headaches, and fever. It is essential for healthcare providers to monitor patients for these side effects and manage them accordingly to ensure the safe and effective use of this medication.
Used in Inhibitor Development Monitoring:
The development of inhibitors to ANTIHEMOPHILIC FACTOR C, HUMAN is a potential concern for patients with hemophilia A. It is crucial to monitor patients for the emergence of these inhibitors, as they can reduce the effectiveness of the treatment and complicate the management of the disorder.
Check Digit Verification of cas no
The CAS Registry Mumber 9001-29-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 9,0,0 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.Calculate Digit Verification of CAS Registry Number 9001-29:
(6*9)+(5*0)+(4*0)+(3*1)+(2*2)+(1*9)=70
70 % 10 = 0
So 9001-29-0 is a valid CAS Registry Number.
9001-29-0Upstream product
9001-29-0Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 9001-29-0
ANTIHEMOPHILIC FACTOR C, HUMAN
